| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
| mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.0009 |
| mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.001 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |